Testing effectiveness (Phase 2)Study completedNCT00001564
What this trial is testing
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
Who this might be right for
Ewing's SarcomaRhabdomyosarcoma
National Cancer Institute (NCI) 30